WSTAM
CLB icon

Wilbanks Smith & Thomas Asset Management’s Core Laboratories CLB Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-60
Closed -$7K – 515
2018
Q3 		$7K Buy
+60
New +$6.77K ﹤0.01% 1119

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's CLB Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 60 shares — an estimated $7K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in CLB in Q3 2018 and held it in 1 quarter. The position peaked at $7K in Q3 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 60 Core Laboratories shares in Q4 2018, an estimated $7K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Core Laboratories in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Core Laboratories position peaked at $7K in Q3 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.